Archived Content

The content on this page is provided for reference purposes only. This content has not been altered or updated since it was archived.

For Consumers

FDA Approval of Generic Ribavirin for Treatment of Chronic Hepatitis C

On April 6, 2004, FDA approved two generic versions of the drug, ribavirin, Ribavirin Capsules, 200 mg, made by Geneva Pharmaceuticals, and Ribasphere Capsules, 200 mg, made by Three Rivers Pharmaceuticals, L.L.C., for the treatment of Chronic Hepatitis C.

Richard Klein
Office of Special Health Issues
Food and Drug Administration

Kimberly Struble
Division of Antiviral Drug Products
Food and Drug Administration

Page Last Updated: 08/01/2014
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.